The therapeutic potential of PGC-1α in AD may involve restoring mitochondrial fission-fusion dynamics and normalizing its distribution in AD-affected brains (Shi et al., 2024; Wang et al., 2022a). The gene discussed is PPARGC1A; the disease is Alzheimer disease.